Conservest Capital Advisors, Inc. Pfizer Inc Transaction History

Conservest Capital Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$41.75 - $54.5 $208 - $272	5 Added 0.1%	4,815 $0
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $20,873 - $25,481	-477 Reduced 9.02%	4,810 $210,000
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $22,706 - $26,922	488 Added 10.17%	5,287 $277,000
Q1 2022 Apr 12, 2022	BUY	$45.75 - $56.69 $228 - $283	5 Added 0.1%	4,799 $248,000
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $165 - $245	4 Added 0.08%	4,794 $283,000
Q3 2021 Oct 13, 2021	BUY	$39.25 - $50.42 $188,007 - $241,511	4,790 New	4,790 $206,000
Q1 2018 Apr 09, 2018	SELL	$31.91 - $37.02 $180,770 - $209,718	-5,665 Closed	0 $0
Q4 2017 Jan 10, 2018	BUY	$33.26 - $35.29 $188,417 - $199,917	5,665	5,665 $205,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Conservest Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Conservest Capital Advisors, Inc. with notifications on news.